Bladder cancer is the fourth most common cancer in men in the United States; however, it also occurs in women, though to a lesser degree. Though several factors are believed to increase the risk of developing bladder cancer, cigarette smoking is the biggest single risk factor. Symptoms can include visible and microscopic blood in the urine, increased frequency of urination, and a sudden onset of the desire to void.
Most bladder cancers are diagnosed via the use of cystoscopy, a procedure in which the urologist views the inside of the bladder using a fiberoptic scope. This same procedure is used to test for recurrence after the cancer has been removed. In addition to undergoing recommended medical treatments, nutritional supplements and lifestyle changes can reduce the chance of bladder cancer recurrence.
TREATMENTS
- Minimally invasive removal of the tumor
- Intravesical Therapy
Medications instilled into the bladder, including chemotherapy agents as well as immunotherapy agents - Lifestyle Changes
Cigarette smoking is the largest risk factor, with over 50% of all bladder cancers attributed to smoking. Exposure to certain solvents or chemicals may also contribute.
- Nutrition and Nutritional Supplements
An increased intake of fruits and vegetables, alongside a reduction in animal fat, can help prevent bladder cancer, while supplements may reduce the risk of superficial recurrence - Fluorescence In Situ Hybridization (FISH)
Lifelong surveillance including the use of Fluorescence In Situ Hybridization (FISH) testing for bladder cancer. The FISH test is a DNA probe labeled with fluorescent molecules to help detect the cancer. The test is the first genetic approved by the FDA and can detect bladder cancer up to six months sooner than other tests.